Acrivon Therapeutics, Inc. (ACRV)
1.52
+0.06
(+4.11%)
USD |
NASDAQ |
Apr 02, 16:00
1.52
0.00 (0.00%)
After-Hours: 20:00
Acrivon Therapeutics Shareholders Equity (Quarterly) : 112.52M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Aclarion, Inc. | 12.84M |
| Incyte Corp. | 5.167B |
| Karyopharm Therapeutics, Inc. | -292.93M |
| Erasca, Inc. | 325.17M |
| Humacyte, Inc. | 3.109M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 130.82M |
| Total Liabilities (Quarterly) | 18.30M |
| Debt to Equity Ratio | 0.0241 |
| Current Ratio | 7.689 |
| Net Debt Paydown Yield | 0.34% |